| |
|
|
|
Tenax Therapeutics Inc.  
|
|
1.22 -0.02 (-0.02%) |
10-18 15:48 |
|
Open: |
1.26 |
Pre close: |
1.24 |
Target:
|
1.58
|
|
High: |
1.2603 |
Low: |
1.22 |
Resistance:
|
1.35
1.48
|
|
Volume: |
16,588 |
Market Cap: |
8M |
Support:
|
1.14
0.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.21
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.21  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.29 |
Stochastic Oscillator |
%K(14,3):
|
61.28 |
|
MA(250): |
1.70 |
%D(3): |
55.70 |
|
Average Volume(K) |
3-Month: |
6536
|
52-Week |
High:
|
6.39 |
|
10-Days: |
2576 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
48.13 |
Change(%): |
-75.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.945 |
Return on Equity (ttm) |
-96.0 |
Shares Out. (M) |
6.74 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-54.2 |
Shares Float (M) |
6.35 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.73 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.31 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
182 |
|
Book Value (p.s.) |
1.290 |
EBITDA (p.s.) |
-1.073 |
P/E |
-0.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.80 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.47 |
P/CF |
-1.21 |
|
|
|
|
|
|
